Quotient Clinical showcases RapidFACT™ and six poster publications at AAPS
Posted: 30 September 2014 | | No comments yet
Quotient Clinical, the Translational Pharmaceutics™ company, will present the third annual RapidFACT™ (Rapid Formulation development And Clinical Testing) User Group Meeting…
Quotient Clinical, the Translational Pharmaceutics™ company, will present the third annual RapidFACT™ (Rapid Formulation development And Clinical Testing) User Group Meeting, as well as six poster publications, at the forthcoming 2014 AAPS Annual Meeting and Exposition from the 2nd to 6th of November in San Diego, USA.
The RapidFACT User Group Meeting will focus on the latest applications of formulation design space to overcome solubility and modified release drug delivery challenges, and will include case study presentations from two industry speakers. For full program details, and to register, click here.
The poster publications describe completed programs using Quotient Clinical’s Translational Pharmaceutics platform for a variety of applications. Details of the poster presentations are:
Rapid formulation development and clinical evaluation of ocular formulations of AMA0076 based upon intra-ocular pressure lowering
Abstract ID: AM-14-2692, Poster ID: M1076
Monday, November 3rd, 1:30 – 5:00 pm, Halls B – F
Adaptive manufacturing: a new paradigm to improve efficiency and effectiveness in early oncology development
Abstract ID: AM-14-1787, Poster ID: W4282
Wednesday, November 5th, 9:30 am – 12:30 pm, Halls B – F
Application of formulation design space to drive rapid development and clinical optimization of drug products – 5 years of innovation
Abstract ID: AM-14-3060, Poster ID: W4020
Wednesday, November 5th, 9:30 am – 12:30 pm, Halls B – F
Assessment of the safety, tolerability and pharmacokinetics of single doses of oral dexanabinol in healthy subjects using an adaptive protocol
Abstract ID: AM-14-2471, Poster ID: W5279
Wednesday, November 5th, 1:30 – 4:30 pm, Hall A
Two approaches for determining absolute bioavailability and intravenous pharmacokinetics in first-in-human studies for oral drug products
Abstract ID: AM-14-2494, Poster ID: W5280
Wednesday, November 5th, 1:30 – 4:30 pm, Hall A
Rapid formulation development and clinical evaluation of enabled formulations of IDX-719
Abstract ID: AM-14-2678, Poster ID: R6179
Thursday, November 6th, 8:30 – 11:30 am, Hall A
Quotient Clinical will be located at exhibition booth #1448. Should you wish to arrange a meeting, please email [email protected].
Copies of the posters will be available at www.quotientclinical.com following the presentations.
